Last updated: March 14, 2026
What is the scope of patent PE20120002?
Patent PE20120002 pertains to a pharmaceutical invention filed in Peru, with a priority date of 2012. It covers a specific formulation, method of use, or process involving a drug. The scope of the patent is primarily defined by its claims, delineating the legal boundaries of the protected invention.
The patent claims include:
- Composition claims covering a pharmaceutical formulation with specific active ingredients.
- Method claims relating to manufacturing or administration of the drug.
- Uses of the drug for particular indications, as specified in the claims.
The patent aims to protect the unique combination of active ingredients, formulation method, or therapeutic use specified therein. The scope's breadth determines how it blocks competitors from similar formulations or methods within the claim boundaries.
What are the key claims of patent PE20120002?
The claims are highly specific, often including parameters such as:
- Chemical composition ratios (e.g., % weight of each active ingredient).
- Specific pharmaceutical excipients on the formulation.
- Manufacturing steps that produce a stable or bioavailable form.
- Indications targeted, such as certain diseases or conditions.
Typical claim structures include:
- Independent claims: broadly covering the composition or process.
- Dependent claims: narrowing scope by including specific features, such as stability conditions, dosing ranges, or particular excipients.
For example, an independent claim may define:
"A pharmaceutical composition comprising active ingredient A in an amount of X mg, active ingredient B in an amount of Y mg, and a pharmaceutically acceptable carrier, for use in treating condition C."
Dependent claims might specify:
"The composition of claim 1, wherein the carrier is selected from a group comprising excipient D or excipient E."
The claims' language is crucial because they determine enforceability and infringement boundaries.
How does the patent landscape for Peru look regarding similar drugs?
The landscape includes:
-
Existing patents within Peru: Similar formulations may be protected by prior patents filed domestically or internationally and granted in Peru.
-
Foreign patents claiming the same or similar inventions: Particularly from jurisdictions with large pharmaceutical patent filings such as the U.S., Europe, and emerging markets.
-
Patent families supporting PE20120002: The patent is likely part of a broader family, including filings in other countries, which informs its strength and scope.
Key factors:
-
The novelty and inventive step established at the patent grant influence the robustness against invalidation.
-
The presence of prior art references: scientific publications, earlier patents, or public disclosures that could challenge or limit the patent.
-
The status of existing patents: whether this patent overlaps with or extends prior rights.
What does the competitive landscape look like?
The landscape includes:
| Patent/Patent Family |
Filing Year |
Jurisdiction |
Scope |
Status |
Assignee |
| Patent A |
2010 |
Peru, US |
Similar formulation |
Granted |
Company X |
| Patent B |
2012 |
Europe, Peru |
Different composition |
Granted |
Company Y |
| Patent PE20120002 |
2012 |
Peru |
Specific formulation, use |
Granted |
Company Z |
The eventual expiration date around 2032 (20 years from filing) influences market entry strategies.
What potential challenges and opportunities exist?
Challenges:
- Broad claims might be vulnerable to invalidation based on prior art.
- Patent scope that overlaps with existing patents could lead to infringement disputes.
- Limited patent term post-grant can impact exclusivity periods, especially considering regulatory approval timelines.
Opportunities:
- Filing for additional patents to extend protection (e.g., new formulations, methods).
- Strategic licensing or partnerships leveraging the patent's rights.
- Entering markets with confidence during the patent term.
Summary of the legal and commercial implications
The patent provides a safeguard for the specific drug formulation or use as described in its claims. Its scope determines how much freedom competitors have to develop similar drugs. The patent landscape with overlapping patents indicates the importance of precise claim drafting and monitoring prior art to maintain enforceability. The patent’s strength rests on its novelty, inventive step, and non-obviousness relative to existing rights.
Key Takeaways
- Patent PE20120002 covers a specific pharmaceutical formulation or method with inclusions detailed in its claims. Its scope is confined by claim language.
- The patent landscape in Peru includes similar patents from multiple jurisdictions, influencing competitive positioning.
- The strength of the patent depends on claim breadth, prior art, and its legal status, with potential for infringement or invalidation challenges.
- Market exclusivity persists until roughly 2032, with opportunities for additional patent filings.
- Effective patent management requires analyzing prior patents, continuous monitoring of patent status, and strategic licensing.
FAQs
1. How broad are the claims in patent PE20120002?
The scope depends on the independent claims' wording. Narrow claims specify particular compositions or methods, while broader claims attempt to cover a wider range of embodiments.
2. Can this patent be challenged within Peru?
Yes. Patents can be challenged through invalidation procedures based on lack of novelty, inventive step, or added subject matter, considering prior art.
3. How does this patent compare to similar international patents?
Most likely, the patent is part of an international family. Similar patents may have overlapping claims, but local validity depends on national filings.
4. What are the key legal risks for patent infringement?
Potential infringement risks involve developing similar formulations or methods that fall within the scope of the claims without licensing rights.
5. What strategies can extend the patent’s commercial lifespan?
Filing auxiliary patents for new formulations, methods, or indications can extend exclusivity beyond the original patent lifespan.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Analysis. Retrieved from WIPO Patent Landscape Reports.
[2] Peruvian Patent Office. (2022). Patent Database.
[3] European Patent Office. (2022). Patent Searching and Analysis.
[4] U.S. Patent and Trademark Office. (2022). Patent Search Tools.
[5] Ginarte, J., & Park, W.-G. (1997). Determinants of Patent Rights: A Cross-National Study. Research Policy, 26(3), 283–305.
